ArticleDer Urologe. Ausg. A2022

[Factors influencing the choice of androgen deprivation therapy for patients with hormone-sensitive prostate cancer : Results of the ProComD study].

J Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.